Objective-We have previously shown an increased expression of complement 3 (C3) in the perivascular adipose tissue (PVAT) in the deoxycorticosterone acetate (DOCA)-salt hypertensive model. This study aims to examine the role and underlying mechanism of C3 in PVAT for understanding the pathogenesis of hypertensive vascular remodeling further. Approach and Results-The role of C3 in macrophage polarization was investigated using peritoneal macrophages from wild-type and C3-deficient (C3KO) mice because we found that C3 was primarily expressed in macrophages in PVAT of blood vessels from DOCA-salt mice, and results showed a decreased expression of M1 phenotypic marker in contrast to an increased level of M2 marker in the C3KO macrophages. Bone marrow transplantation studies further showed in vivo that DOCA-salt recipient mice had fewer M1 but more M2 macrophages in PVAT when the donor bone marrows were from C3KO compared with those from wild-type mice. Of note, this macrophage polarization shift was accompanied with an ameliorated vascular injury. Furthermore, we identified the complement 5a (C5a) as the major C3 activation product that was involved in macrophage polarization and DOCA-salt-induced vascular injury. Consistently, in vivo depletion of macrophages prevented the induction of C3 and C5a in PVAT, and ameliorated hypertensive vascular injury as well. 
P erivascular adipose tissue (PVAT), surrounding the systemic blood vessels, is thought to be an important, active component of the vasculature, with pivotal roles in vascular health and disease. [1] [2] [3] Our previous study has demonstrated that complement 3 (C3) deposition notably increased in the PVAT of deoxycorticosterone acetate (DOCA)-salt hypertensive models. 4 The complement system is an important component of innate immunity. 5, 6 On activation of the complement system, the formation of C3 convertases results in the cleavage of the central complement component C3 to complement 3b (C3b) and complement 3a (C3a). The released C3a and complement 5a (C5a), derived from C3b and complement 5 (C5) cleavage, trigger further immune reactions and inflammatory disorders. 7, 8 However, whether the abnormal complement activation is involved in the hypertensive vascular injury, and thus the detailed cellular and molecular mechanisms underlying complement-mediated vascular inflammation in PVAT remain poorly understood.
Chronic low-grade inflammation within the PVAT is an important casual factor of vascular disorders. 9, 10 The infiltration and activation of macrophages found dispersed throughout PVAT are responsible for the inflammatory processes in hypertensive models. 11 Two primary macrophage subsets in the adipose tissue have now been well characterized. One subset is termed as classically activated M1 macrophage and the other is considered as alternatively activated M2 macrophage. M1 macrophages produce proinflammatory cytokines, including interferon-γ (IFN-γ), inducible nitric oxide synthases (iNOS), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α). M2 macrophages are linked to the activation of anti-inflammatory mediators, including arginase-1 (Arg-1), found in inflammatory zone-1, IL-10, and chitinase 3-like-3 (YM1). [12] [13] [14] [15] Several reports show that complement activation induced inflammatory factor expression in macrophages. macrophage activation and their causal roles in hypertensive vascular injury are still not clear. Here, we investigate the role of complements in macrophage activation in PVAT of DOCAsalt hypertensive mice. Through bone marrow transplantation (BMT) approaches, we demonstrate the involvement of complement-mediated macrophage polarization in DOCAsalt hypertension-related vascular inflammation. Our findings show that C3-deficiency results in decreased M1 macrophage phenotype markers and increased M2 macrophage phenotype markers. Bone marrow-specific C3-deficiency ameliorated DOCA-salt-induced hypertensive vascular hypertrophy and fibrosis, associating with shifting macrophage phenotype to less M1 and more M2.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Complements Are Expressed in Macrophages in the PVAT of DOCA-Salt Hypertensive Mice
To investigate the role of complement expression in hypertensive blood vessels, we used a mouse DOCA-salt hypertension model. As shown in Figure I in the online-only Data Supplement, DOCA-salt treatment resulted in a dramatic increase in media:lumen ratio ( Figure 1A ) and arterial fibrotic area ( Figure 1B) , and the fibrotic area in DOCA-salt mice seemed to be more diffused in the adventitia around PVAT. C3 expression in mesenteric arteries was detected by immunostaining. We found that C3 was preferentially expressed in the PVAT rather than mesenteric arterial layers and primarily colocalized with F4/80-positive macrophages ( Figure 1A ), suggesting that macrophages are the major source of C3 in the PVAT. We also detected significantly increased expression of C3a and C5a, the products of C3 downstream activation ( Figure 1B) . These results suggest a potential role of complement activation and macrophages in hypertension-related vascular injury.
Complements Regulate Macrophage Polarization
To delineate the role of C3 in macrophages, we first investigated the expression of C3 in peritoneal macrophages with different phenotypes. We found that C3 mRNA expression increased in macrophages polarized toward a proinflammatory M1 phenotype by lipopolysaccharide treatment (Figure 2A ), whereas C3 reduced in macrophages polarized toward an antiinflammatory M2 phenotype by IL-4 treatment ( Figure 2B ). To assess the function of C3 in macrophage phenotype transition further, we cultured peritoneal macrophages from wild-type (WT) and C3KO mice and analyzed macrophage phenotype marker expression. We found that C3KO macrophages had a significantly decreased expression of M1 markers (IFN-γ, iNOS, IL-6, and TNF-α) after lipopolysaccharide treatment compared with WT macrophages ( Figure 2C ; Figure IIA online-only Data Supplement). In contrast, C3 macrophages had an increased expression of M2 markers (Arg-1, found in inflammatory zone-1, IL-10, and YM-1) after IL-4 treatment ( Figure 2D ; Figure IIB in the online-only Data Supplement). In addition, we investigated the role of C3 in the activation of key transcription factors involved in macrophage phenotype transition, such as p65 nuclear factor kappa B and signal transducers and activators of transcription 6 (STAT6).
18,19 C3KO macrophages decreased p65 phosphorylation in response to proinflammatory stimuli (lipopolysaccharide), but increased STAT6 phosphorylation in response to anti-inflammatory stimuli (IL-4; Figure 2E ). Furthermore, we performed chromatin immunoprecipitation assays to demonstrate the activity of p65 and STAT6 in vivo. Results showed that p65 binding to the promoter of Tnfα (M1 marker) was decreased, whereas STAT6 binding to the promoter of Arg1 (M2 marker) was .05 vs WT LPS (or IL-4) treatment, 1-way ANOVA followed by the post hoc Dunnett test. E, Peritoneal macrophages were extracted before further treatment with 100 ng/mL LPS or 10 ng/mL IL-4 for 0, 0.5, 1, and 2 hours before cell lysis. Lysates were blotted on sodium dodecyl sulfate polyacrylamide gel electrophoresis for p-p65, t-p65, p-Stat6, and t-Stat6 expression; Right, Statistical analysis of 3 independent experiments. F, Binding of p65 and Stat6 to M1-and M2-associated genes (TNF-α and Arg-1) was assessed by chromatin immunoprecipitation 0 or 2 hours after stimulation by 100 ng/mL LPS or 10 ng/mL IL-4; Right, Statistical analysis of 3 independent experiments. Data are presented as mean±SD and statistically analyzed by 1-way ANOVA followed by the post hoc Dunnett test. Con indicates control.
increased in C3KO macrophages ( Figure 2F ). These observations together suggest that C3 is critical for macrophage polarization toward the M1 phenotype by promoting nuclear factor kappa B-dependent transcriptional activity.
Bone Marrow-Specific Deficiency of C3 Alters Macrophage Polarization
To Figure 3C ). These were further confirmed by immunofluorescent staining, which showed a similar extent of macrophage infiltration (anti-F4/80) in PVAT between the 2 groups. However, M2 marker (Arg-1) was increased, whereas M1 marker (iNOS) was decreased in BMT-C3KO mice compared with BMT-WT mice ( Figure 3D and 3E ).
Bone Marrow-Specific Deficiency of C3 Attenuates DOCA-Salt-Induced Vascular Injury
To examine the expression of inflammatory mediators in PVAT after BMT-C3KO, we performed protein array analysis. As shown in Figure 4A , proinflammatory molecules (IFN-γ, TNF-α, RANTES, IL-12p70, and MCP1 [monocyte chemotactic protein 1]) decreased, whereas anti-inflammatory molecules (IL-4, IL-10, IL-13, and IL-1Rα) increased in the PVAT of BMT-C3KO compared with BMT-WT mice. These were further confirmed by the detection of representative genes (IFN-γ, TNF-α, and IL-10) in the PVAT ( Figure 4B ). Next, we performed histological analyses of the mesenteric arteries and found that vascular hypertrophy ( Figure 4C ) and fibrosis ( Figure 4D ) were largely improved in BMT-C3KO mice.
Bone Marrow-Derived C3 Rescues Vascular Injury in C3-Decificient Mice
Although our data pointed to bone marrow-derived macrophages as the dominant C3-expressing cells in DOCA-salt mice, there nevertheless, remained the possibility of a lowlevel C3 expression in adipocytes and vascular cells potentially playing a critical role in the vascular injury. To assess the role of local C3 expression in the PVAT, we used C3KO mice as recipient, which were transplanted with C3KO or WT marrow and subjected to DOCA-salt hypertensive model. Flow cytometric analysis showed that WT BMT (WT-to-C3KO) increased the percentage of M1 and decreased the percentage of M2 macrophage compared with C3KO BMT (C3KO-to-C3KO; Figure IVA in the online-only Data Supplement). Histological analyses of mesenteric arteries showed that WT-to-C3KO rescued vascular hypertrophy and fibrosis ( Figure IVB in the online-only Data Supplement). These suggest that WT BMT abolishes the beneficial vascular phenotype of C3 deficiency in DOCA-salt models.
C5a Regulates Macrophage Polarization and Aggravates Vascular Injury
The findings with C3KO macrophages pointed to a potential inflammatory response of the components of the complement system downstream of C3. To provide further evidence for this hypothesis, we assessed the active components generated on C3 cleavage, C3a and C5a. 7, 8 Results showed that C3a peptide agonist (C3a) had no significant effect on macrophage polarization ( Figure V in the online-only Data Supplement), whereas C5a peptide agonist (C5a) treatment of peritoneal macrophages displayed higher mRNA levels for M1 markers (IFN-γ, iNOS, IL-6, and TNF-α), and lower levels for M2 markers (Arg-1, found in inflammatory zone-1, IL-10, and YM-1; Figure 5A and 5B; Figure Figure 5C ). C5a peptide agonist also aggravated vascular hypertrophy and fibrosis in DOCAsalt mice ( Figure 5D ). These findings suggest that complements regulate macrophage polarization and contribute to the DOCA-salt hypertensive vascular remodeling process largely via C5a.
Macrophage Depletion Reduces C3 and C5a Levels and Attenuates Vascular Injury
To determine the role of macrophages in mediating complement expression and vascular remodeling, we investigated the effect of macrophage depletion by clodronate liposomes (Clod) 20 on pathological vascular remodeling in DOCAsalt mice. Flow cytometric analysis of the peritoneal fluid revealed that an efficient depletion of F4/80 positive cells was achieved ( Figure 6A ). Macrophage depletion attenuated the induction of C3 ( Figure 6B ) and C5a expression ( Figure 6C ) in DOCA-salt mice, as well as vascular hypertrophy and fibrosis ( Figure 6D ). These observations suggest that the function of the complement system in hypertensive vascular injury is dependent on macrophages.
Hypertension is well established as a stimulus for vascular hypertrophy and remodeling. It was, therefore, important to determine whether complements altered blood pressure in this model. DOCA-salt treatment was shown to cause a significant increase in blood pressure. BMT or systemic C5a peptide agonist treatment did not alter blood pressure in DOCA-salt mice. Macrophage depletion (Clod) resulted in an augmented increase of blood pressure ( Figure VIII in the online-only Data Supplement). These results demonstrate that the effects of complements on perivascular inflammation and vascular remodeling are blood pressure-independent.
Discussion
In this study, we provide evidence demonstrating that bone marrow-specific deficiency of C3 protects mice from hypertensive vascular injury. A comparison of the expression patterns of phenotype-specific markers in macrophages allows us to conclude that complements modulate M1/M2 polarization, which in turn, contributes to DOCA-salt hypertensive vascular inflammation. Furthermore, we found that C5a but not C3a regulates macrophage polarization and contributes to hypertension-related vascular injury.
Herein, we first show that complements are expressed in the perivascular macrophages and regulate macrophage polarization in DOCA-salt hypertensive mice. The involvement of the complement system in the pathological processes of hypertension-induced target organ damage is well appreciated. 21 However, the source and distribution of complements have not been well studied in hypertensive vascular disorders. C3 is essential for the critical steps of complement activation, and mainly produced by the liver, also secreted by activated macrophages at inflammation sites and by adipocytes. 22 Several reports have suggested that complement molecules are mainly detected around perivascular areas in animal models. 7, 8 Macrophage infiltration and activation in PVAT are well documented as for loss of anticontractile function in perivascular fat from aldosterone-induced inflammation. 11 It is of interest that the recruitment of macrophages after mineralocorticoid/ salt administration has previously been suggested as the key mechanism behind the development of cardiovascular injury, but the mechanism by which macrophage activation increases in mineralocorticoid administration is still unclear. In this context, it is also worth noting that macrophages generally infiltrate in perivascular tissue and colocalize with complements. We have provided evidence in this study that complement upregulation induces macrophage activation in DOCA-salt mice. Macrophage depletion decreases complement expression, including C3 and C5a in PVAT, which demonstrates that macrophages in PVAT are the main sources of complements in DOCA-salt mice.
Another important issue, whether the complement system is implicated in the macrophage-mediated hypertensive vascular inflammation, has not been well studied. Here, consistent with a previous report, 23 we show that C3 mRNA expression is increased in M1 macrophages, but decreased in M2 macrophages. Besides, C3KO peritoneal macrophages exhibit decreased lipopolysaccharide-induced M1 and enhanced IL-4-induced M2 marker expression. More importantly, BMT experiments reveal that complement expression in bone marrow-derived macrophages rather than resident perivascular cells is responsible for DOCA-salt-induced pathological change in blood vessels. Bone marrow-specific deficiency of C3 results in decreased production of inflammatory factors in PVAT and amelioration of DOCA-salt-induced vascular injury. It is probably that mineralocorticoid/salt administration induced complement activation in the monocytes and macrophages, which permeate through the endothelium of blood vessels and infiltrate to PVAT. Complement activation promotes M1 but attenuates M2 macrophages and interacts with other cell types and mediators within the perivascular microenvironment to cause pathological changes. Although macrophage depletion with clodronate liposomes results in increased blood pressure in DOCA-salt mice, macrophage blockade contributes to complement inhibition and amelioration of vascular injury in DOCA-salt mice. These data are comparable with previous findings, which show that macrophage ablation, through depletion of lysozyme M-positive monocytes or deletion of macrophage colony-stimulating factor, attenuates hypertension-induced vascular dysfunction in animal models. 24, 25 Taken together, our data first provide definitive in vivo evidence that complements regulate hypertensive vascular remodeling processes via regulating macrophage polarization in PVAT. However, in addition to macrophages, PVAT includes adipocytes and other cells as well. Although our present work reveals a significant role of complementmediated macrophage polarization in DOCA-salt-induced vascular injury, the other cells, especially the abundant adipocytes in the PVAT, may also contribute to hypertensive vascular injury via a distinct pathway. 26 The factors involved in the complement pathway in DOCAsalt-induced vascular injury are also a point of interest. On activation of the complement system, the formation of C3 convertases results in the cleavage of C3 to C3b and C3a. Deposition of C3b on cell surfaces is important for opsonization and phagocytosis. The released anaphylatoxin C3a and C5a that derives from C5 cleavage trigger further immune reactions on binding to their cellular receptors. 6, 7 Previous studies show that C1q, C3, C3a, C3c, C5a and C5b-9 are observed around blood vessels in angiotensin-II-induced hypertension. 21 Among these, C3a and C5a are potent monocyte/macrophage chemoattractants. C3a induces exaggerated growth, a synthetic phenotype and angiotensin-II production in spontaneously hypertensive rats-derived vascular smooth muscle cells. 27 It is also known that C3a can enhance the secretion of lipopolysaccharide-induced IL-1β in monocytes. 28 However, our data suggest that the C3a peptide agonist does not regulate macrophage polarization in vitro, although the role of C3a peptide agonist in perivascular inflammation remains to be investigated. We have found that the C5a peptide agonist enhances M1 polarization and attenuates M2 polarization. C5a peptide agonist administration in vivo aggravates DOCAinduced vascular hypertrophy and fibrosis, accompanied by increased M1 macrophages in PVAT. Our finding is in line with a recent report showing that C5a but not C3a mediates hypertensive cardiac inflammation and remodeling in angiotensin-II-induced hypertension. 29 However, we first provide evidence that the change of macrophage polarization induced by bone marrow-derived C5a in PVAT is the major cellular mechanism for complement-mediated pathological processes in the DOCA-salt hypertensive vascular injury model. Taken together, we propose a model: DOCA-salt administration initiates perivascular macrophages-derived complement cascade activation and subsequently induces C5a production, which promotes M1 inflammatory macrophage recruitment and exacerbates hypertension-related vascular hypertrophy and fibrosis.
In conclusion, our findings provide a novel insight that perivascular immune microenvironment regulated by complement cascade contributes to hypertension-related vascular inflammation, in which C5a-mediated macrophage polarization is crucial for the pathological processes in PVAT. Given the importance of complement-mediated macrophage activation in PVAT, the potential changes of perivascular adipocytes and adipokines (well known to be involved in the regulation of vascular health and diseases) deserve to be investigated further in the future. Notwithstanding the complexity of human hypertension compared with the mouse model, our unique observations indicate an attractive possibility that the complement system could serve as therapeutic tools for inhibiting hypertensive vascular injury.
